GT Biopharma, Inc.·4

Oct 21, 9:13 PM ET

URBAN ALAN LOUIS 4

4 · GT Biopharma, Inc. · Filed Oct 21, 2024

Insider Transaction Report

Form 4
Period: 2024-10-17
Transactions
  • Award

    Option to purchase Common Stock

    2024-10-17+23,33523,335 total
    Exercise: $2.11Exp: 2034-10-16Common Stock (23,335 underlying)
Footnotes (1)
  • [F1]1/36th of the shares vest on the monthly anniversary of June 3, 2024 until fully vested, subject to full acceleration in the event the reporting person is involuntarily terminated by the registrant without Cause (as defined in the reporting person's Employment Agreement dated June 7, 2024), resignation by the reporting person for Good Reason (as defined in the reporting person's Employment Agreement dated June 7, 2024), or in the event of a Change in Control (as defined in the registrant's 2022 Omnibus Incentive Plan).

Documents

1 file
  • 4
    ownership.xmlPrimary